Ania Jastreboff, MD
Enriched profileHarvey and Kate Cushing Professor of Medicine (Endocrinology) and Professor of Pediatrics · Yale School of Medicine
Ania Jastreboff is Harvey and Kate Cushing Professor of Medicine (Endocrinology) and Professor of Pediatrics at Yale School of Medicine. OpenAlex indexes 121 publications with 11,205 citations (h-index 33); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Ania Jastreboff, MD, PHD, is Harvey and Kate Cushing Professor of Medicine (Endocrinology) and Professor of Pediatrics at Yale School of Medicine. The public record shows 121 publications with 11,205 citations (h-index 33), centered on Obesity. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 17 companies, 4 NIH-funded awards (2014–2026).
- Most recent indexed publication: 2026 · The New England journal of medicine
- Top research focus: Obesity
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 17 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Sponsor: Eli Lilly and Company
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Sponsor: Eli Lilly and Company
Industry payments
Updated 27 Aug 2026
17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year202572 payments$54,247openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year202513 payments$36,374openpaymentsdata.cms.gov ↗
- Novo Nordisk ASProgram year202518 payments$33,079openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%GLP-1 receptor agonist67.9%Mounjaro60%Ozempic40%Part D<11 patientsBiguanide (metformin)32.1%Metformin Hcl Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
4 NIH research awards on record, funded 2014–2026 per NIH RePORTER. The latest:
- Semaglutide Dose Effects on Metabolic and Stress Hormones, Craving and Alcohol Use Outcomes
Yale University
FY2026$752,580R01AA032779 - GLP-1 analogue effects on food cues, stress, motivation for highly palatable foods, and weight
Yale University
FY2024$651,452R01DK099039 - GLP-1 analogue effects on food cues, stress, motivation for highly palatable foods, and weight
Yale University
FY2023$697,726R01DK099039
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Survodutide Once Weekly for the Treatment of Adults with Obesity.
The New England journal of medicine
Article2026 - Toward Health Equity: A Workshop Report on the State of the Science of Obesity Interventions for Adults.
Obesity (Silver Spring, Md.)
Article2025 - Efficacy of antiobesity medications for weight reduction in older adults: a systematic review.
Obesity (Silver Spring, Md.)
Review2025 - Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial.
The New England journal of medicine
Clinical Trial2025 - Tirzepatide for reduction of morbidity and mortality in adults with obesity: rationale and design of the SURMOUNT-MMO trial.
Obesity (Silver Spring, Md.)
Article2025
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/ania-jastreboff-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/ania-jastreboff-md-phd-682600a2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Ania-M-Jastreboff-53657047
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/YaleSchoolOfMedicine/posts/new-options-for-treating-obesity-in-a-recent-phase-ii-clinicaltrial-ysms-ania-ja/1547388996602780
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Instagram
instagram.com/reel/DAGim6WJeJ3
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - LinkedIn
linkedin.com/posts/flytehealth_flytehealth-clinical-advisor-ania-jastreboff-activity-7229894643490897920-S-WR
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗
- Board Certified: Endocrinology
Diabetes and Metabolism; Pediatric Endocrinology; Obesity Medicine; Internal Medicine; Pediatrics
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →endocrine.org ↗
Editorial & leadership roles
journal and society appointments- Director
Yale Obesity Research Center (Y-Weight)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - Co-Director
Yale Center for Weight Management
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗ - Director of Weight Management and Obesity Prevention
Yale Stress Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →endocrine.org ↗
Awards & honors
honors on the public record- New York Times Best-Selling Author
"Enough: Your Health, Your Weight, and What It's Like to Be Free" (with Oprah Winfrey), 2025-2026
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ynhh.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.yale.edu ↗
- Author interview / feature on CBS Sunday Morning
TODAY, and The View with Oprah Winfrey regarding obesity and anti-obesity medications (tied to book "Enough")
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Harlan Krumholz, MD
Yale School of Medicine
Eric Winer, MD
Yale School of Medicine
Roy Herbst, MD, PhD
Yale School of Medicine
Robert Rosenheck, MD
Yale School of Medicine